Healthcare giant Pfizer ( PFE 2.24%) has been offering a high yield for some time. But that hasn't been enough to get ...

Pfizer and Tris Pharma agreed to a $41.5 million settlement with Texas over claims they manipulated quality-control testing ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

Akeso has a validated process in place for developing antibodies but does require US exposure to meet its lofty valuation.

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Texas Attorney General Paxton secures a $41.5 million settlement with Pfizer and Tris Pharma over allegations of providing ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to ...

As a damning report finds all four UK governments failed to appreciate the scale of the threat posed by COVID-19 or the ...

The UK's drug cost-effectiveness watchdog has recommended Alnylam Pharmaceuticals' heart disease drug, ensuring access for ...

The settlement resolves a 2023 lawsuit that accused the pharmaceutical companies of manipulating quality control tests of a medication used to treat ADHD.